Inventor · disambiguated record
Stephen B. Liggett
Also filed as: LIGGETT STEPHEN · LIGGETT STEPHEN B · LIGGETT STEPHEN BRYANT
22 granted patents·10 pending applications·186 citations·filing 1997–2025
95Inventor score
Files withUNIV CINCINNATI8LIGGETT STEPHEN B7UNIV SOUTH FLORIDA5GENAISSANCE PHARMACEUTICALS3UNIV COLORADO REGENTS3
Top patents by PatentIndex Score
32 records- 0195US7572603B2Alpha-2 adrenergic receptor polymorphismsUNIV CINCINNATI·Filed 2005·Granted Aug 11, 2009·63 cites·3 claims
- 0291US7678824B2Methods for treatment with bucindolol based on genetic targetingUNIV COLORADO REGENTS·Filed 2005·Granted Mar 16, 2010·13 cites·16 claims
- 0385US8093286B2Methods for treatment with bucindolol based on genetic targetingLIGGETT STEPHEN B·Filed 2007·Granted Jan 10, 2012·5 cites·22 claims
- 0483US9579315B2Methods of treating obstructive lung diseases using bitter tastantsLIGGETT STEPHEN B·Filed 2011·Granted Feb 28, 2017·7 cites·20 claims
- 0582US7041810B2Alpha-2 adrenergic receptor polymorphismsUNIV CINCINNATI·Filed 2001·Granted May 9, 2006·10 cites·4 claims
- 0680US6797472B1Variation in drug response related to polymorphisms in β2-adrenergic receptorGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted Sep 28, 2004·7 cites·4 claims
- 0779US6586183B2Association of β2-adrenergic receptor haplotypes with drug responseGENAISSANCE PHARMACEUTICALS·Filed 2001·Granted Jul 1, 2003·13 cites·10 claims
- 0877US7449292B2Methods for predicting relative efficacy of a beta blocker therapy based on a B1-adrenergic receptor polymorphismUNIV CINCINNATI·Filed 2004·Granted Nov 11, 2008·12 cites·8 claims
- 0976US8080578B2Methods for treatment with bucindolol based on genetic targetingLIGGETT STEPHEN B·Filed 2007·Granted Dec 20, 2011·1 cites·28 claims
- 1076US7229756B1Alpha-2B-adrenergic receptor polymorphismsUNIV CINCINNATI·Filed 2000·Granted Jun 12, 2007·5 cites·11 claims
- 1175US7211386B2Alpha-2A-adrenergic receptor polymorphismsUNIV CINCINNATI·Filed 2003·Granted May 1, 2007·4 cites·5 claims
- 1268US7642052B2Heart failure assessment based on alpha-2C adrenergic receptor polymorphismsUNIV CINCINNATI·Filed 2003·Granted Jan 5, 2010·4 cites·8 claims
- 1367US2024207359A1Inhibition of beta-arrestin oligomerization in tauopathyUNIV SOUTH FLORIDA·Filed 2024·Application pending·0 cites
- 1465US2015276717A1Methods for treatment with bucindolol based on genetic targetingUNIV COLORADO REGENTS·Filed 2014·Application pending·0 cites
- 1562US12024502B2Biased adrenergic agonistsUNIV SOUTH FLORIDA·Filed 2022·Granted Jul 2, 2024·0 cites·14 claims
- 1662US2018156782A1Methods for Treatment with Bucindolol Based on Genetic TargetingUNIV COLORADO REGENTS·Filed 2017·Application pending·0 cites
- 1761US12257248B2Bronchodilators for treating obstructive lung diseaseUNIV SOUTH FLORIDA·Filed 2021·Granted Mar 25, 2025·0 cites·16 claims
- 1861US8916603B2Methods for treatment with bucindolol based on genetic targetingLIGGETT STEPHEN B·Filed 2011·Granted Dec 23, 2014·0 cites·5 claims
- 1960US6498009B1β-adrenergic receptor polymorphismsUNIV CINCINNATI·Filed 1997·Granted Dec 24, 2002·19 cites·42 claims
- 2058US2025268888A1Bronchodilators for treating obstructive lung diseaseUNIV SOUTH FLORIDA·Filed 2025·Application pending·0 cites
- 2158US2009092964A1Methods for Individualizing Cardiovascular Disease Treatment Protocols Based on Beta-1 Adrenergic Receptor HaplotypeUNIV CINCINNATI·Filed 2008·Application pending·0 cites
- 2257US11896644B2Inhibition of beta-arrestin oligomerization in tauopathyUNIV SOUTH FLORIDA·Filed 2021·Granted Feb 13, 2024·0 cites·7 claims
- 2355US6861217B1Variation in drug response related to polymorphisms in the β2-adrenergic receptorGENAISSANCE PHARMACEUTICALS·Filed 1999·Granted Mar 1, 2005·14 cites·2 claims
- 2449US8530160B2G-protein coupled receptor kinase-5 polymorphismDORN GERALD W·Filed 2007·Granted Sep 10, 2013·0 cites·4 claims
- 2547US10927375B1Compositions and methods to reduce beta-agonist-mediated tachyphylaxisLIGGETT STEPHEN B·Filed 2019·Granted Feb 23, 2021·0 cites·8 claims
- 2647US8071287B2Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase Polymorphism in asthma and reversible bronchial obstructionLIGGETT STEPHEN B·Filed 2006·Granted Dec 6, 2011·0 cites·2 claims
- 2747US2009228995A1Polymorphisms and Haplotypes of the Alpha 2C Adrenergic Receptor GeneLIGGETT STEPHEN BRYANT·Filed 2005·Application pending·0 cites
- 2846US2004192625A1Adrenergic receptor overexpression in airway tissues for the treatment of airway obstructive diseasesFiled 2001·Application pending·0 cites
- 2942US2003091998A1Association of beta2-adrenergic receptor haplotypes with drug responseFiled 2001·Application pending·0 cites
- 3041US2010233677A1Full genome sequences of human rhinovirus strainsLIGGETT STEPHEN B·Filed 2010·Application pending·0 cites
- 3141US2003039979A1Association of beta2-adrenergic receptor haplotypes with drug responseFiled 2001·Application pending·0 cites
- 3240US6316188B1Histamine-N-methyltransferase variants associated with histaminergic diseaseMAYO FOUNDATION·Filed 1998·Granted Nov 13, 2001·9 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Stephen B. Liggett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →